Belite Bio, Inc. (BLTE)

177.58 -12.72 (-6.68%) USD  |  NASDAQ  |  Mar 02, 16:00
175.10 -2.48 (-1.40%) After-Hours: 20:00
More

Belite Bio Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for BLTE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
Ocugen, Inc. Upgrade
IDEAYA Biosciences, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade